Professional Dosing Comparison & Online Prescription Access
Wegovy to Mounjaro Conversion Chart: Understanding Key Differences
When evaluating a wegovy to mounjaro conversion chart, it's essential to understand these are distinct medications with different active ingredients and mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist. This fundamental difference means direct dose conversion isn't medically appropriate - each requires individual clinical assessment. Your prescriber will evaluate your current response, medical history, and treatment goals rather than applying a simple conversion formula.
The online prescription process at EverydayMeds allows licensed UK prescribers to assess both options comprehensively. Our clinical team, registered with GPhC #9012878, reviews each case individually to determine medical suitability. This personalised approach ensures you receive the most appropriate treatment based on your circumstances, not a generic conversion chart. Both medications are prescription-only medicines requiring proper medical oversight for safe, effective use alongside a reduced-calorie diet and increased physical activity.
Wegovy vs Mounjaro Dosing Schedules: Complete Price Breakdown
Wegovy follows a 20-week escalation protocol: 0.25mg (weeks 1-4) at £79.99, 0.5mg (weeks 5-8) at £94.99, 1mg (weeks 9-12) at £99.99, 1.7mg (weeks 13-16) at £139.99, then 2.4mg maintenance from week 17 at £209.99. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) provides the first 12 weeks for £299.99, with discount codes FIRST40 for new customers and DOSE25 for returning patients applied at checkout. This structured approach allows gradual tolerance development whilst monitoring treatment response.
Mounjaro uses a different escalation: 2.5mg for 4 weeks, 5mg for 4 weeks, then 10mg or 15mg maintenance depending on individual response and tolerability. The pricing structure reflects these different dosing requirements, making direct cost comparison between treatments less meaningful than evaluating total treatment value. Both medications are available through our online prescription service, with your prescriber determining the most cost-effective approach based on your clinical needs and treatment goals.
Clinical Evidence Supporting Wegovy to Mounjaro Treatment Decisions
STEP clinical trials demonstrate Wegovy's efficacy, with patients achieving approximately 15% average weight loss at 68 weeks alongside diet and exercise modifications (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed 20% reduction in major adverse cardiovascular events, providing additional clinical value beyond weight management. These outcomes guide prescriber decisions when evaluating treatment options.
Mounjaro's SURMOUNT trials indicate comparable efficacy with different mechanisms of action, though direct comparison between trial results isn't clinically appropriate due to different study designs and populations. Your prescriber will consider individual factors including medical history, contraindications, and treatment preferences rather than relying solely on population-level trial data when determining the most suitable option.
How Wegovy Works: GLP-1 Mechanism for Informed Treatment Choice
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking naturally occurring incretin hormones that regulate appetite and food intake. The medication acts on brain appetite centres, particularly in the hypothalamus, to reduce hunger signals and enhance satiety after smaller meals. This mechanism may help reduce food cravings and portion sizes, supporting sustainable eating pattern changes. The once-weekly injection maintains consistent therapeutic levels, avoiding daily dosing fluctuations. Clinical response typically becomes apparent within 12-16 weeks of treatment, with optimal effects often seen at maintenance dosing alongside lifestyle modifications.
Online Prescription Process: 3-Minute Assessment to Next-Day Delivery
Our streamlined online prescription service begins with a comprehensive 3-minute clinical assessment covering medical history, current medications, BMI calculations, and contraindication screening. Licensed UK prescribers review each application within 3 working days (express 24-hour service available), ensuring thorough medical evaluation without compromising accessibility. Once approved, medications ship via next-day cold-chain delivery, maintaining optimal storage conditions throughout transport. No GP referral is required, though we recommend informing your usual healthcare provider about treatment commencement. The entire process eliminates traditional appointment delays whilst maintaining clinical safety standards through proper medical oversight.
Storage and Practical Considerations: Wegovy vs Mounjaro Handling
Wegovy offers superior storage flexibility, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature stability. This advantage supports travel and lifestyle flexibility, particularly for frequent travellers or those with irregular schedules. Both medications use pre-filled pen devices, though Wegovy's FlexTouch pen design may offer easier handling for some patients. Refrigeration at 2-8°C before first use is required for both treatments, with proper disposal of used pens through household sharps containers or pharmacy take-back programmes. Dose escalation schedules are mandatory for both medications and cannot be accelerated without prescriber guidance.
Wegovy to Mounjaro Prescription Transition: Online Clinical Support
Transitioning between weight management medications requires careful medical supervision rather than simple dose conversion charts. Our online prescription service facilitates these transitions through comprehensive clinical assessment, allowing prescribers to evaluate current treatment response, side effect profiles, and individual circumstances. The assessment considers wash-out periods, potential interaction effects, and optimal timing for medication changes. Licensed prescribers can coordinate treatment transitions whilst maintaining therapeutic continuity.
This personalised approach ensures medically appropriate transitions based on individual clinical response rather than generic conversion protocols. Both Wegovy and Mounjaro are available through EverydayMeds, allowing your prescriber flexibility to recommend the most suitable option or facilitate changes based on treatment evolution. Our clinical team, registered with GPhC #9012878, provides ongoing support throughout treatment transitions, ensuring optimal outcomes and safety monitoring.
Complete Your Wegovy to Mounjaro Assessment: Prescription Access Today
Ready to explore your weight management options through professional medical assessment? Start your 3-minute online clinical evaluation at https://everydaymeds.co.uk/collections/wegovy to connect with licensed UK prescribers who can evaluate both Wegovy and Mounjaro suitability. New customers use discount code FIRST40, whilst returning patients apply DOSE25 at checkout for optimal pricing. Our clinical team reviews each application thoroughly, ensuring you receive appropriate medical guidance rather than generic treatment recommendations. Express prescription approval is available for urgent clinical needs, with next-day delivery maintaining cold-chain integrity throughout the process. Both medications represent significant advances in prescription-only weight management support, and your prescriber will help determine the most appropriate option based on comprehensive medical assessment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
